What if neuroplasticity research targeted the HGF c Met pathway? Dihexa (PNB 0408) is an angiotensin IVderived peptide studied in preclinical models for its role in synaptogenesis and cognitive signaling mechanisms. Human data remains limited. A novel agonist for the HGF receptor MET promotes differentiation of human pluripotent stem cells into hepatocytelike cells Tauran 2022 Development, Growth & Differentiation Wiley Online Library Exploring the science behind Dihexa., Preclinical research examines its interaction with the HGF c Met pathway and associated neuroplasticity markers in laboratory and animal models. Human data Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Therapeutic targeting of HGF c Met pathway. c Met pathway inhibition Download Scientific Diagram The HGF c Met signaling axis. After HGF binding to the c Met receptor Download Scientific Diagram